Additionally, in the context of Alzheimer’s disease (AD) neuroinflammation, lncRNA MALAT1 downregulates the expression of IL-6 and TNF-α while concurrently enhancing IL-10 levels, suggesting the potential therapeutic value of targeting lncRNA MALAT1 in AD [53]. This evidence concerns the gene IL10 and Alzheimer disease.